Frontiers in Pharmacology
Scope & Guideline
Empowering researchers with cutting-edge insights in pharmacology.
Introduction
Aims and Scopes
- Pharmacological Mechanisms and Drug Action:
The journal emphasizes research that elucidates the mechanisms of drug action at molecular, cellular, and systemic levels, contributing to the understanding of how drugs interact with biological systems. - Clinical Pharmacology and Therapeutics:
Publications often focus on the clinical application of pharmacological principles, including studies on drug efficacy, safety, and the pharmacokinetics and pharmacodynamics of various therapeutic agents. - Natural Products and Traditional Medicine:
There is a strong interest in exploring natural compounds and traditional herbal medicines, investigating their pharmacological effects, mechanisms of action, and potential therapeutic applications. - Pharmacogenomics and Personalized Medicine:
Research on genetic variations affecting drug metabolism and response is a significant area, promoting the development of personalized medicine approaches to optimize drug therapies. - Drug Safety and Pharmacovigilance:
The journal covers studies related to drug safety, adverse effects, and pharmacovigilance, highlighting the importance of monitoring and evaluating drug-related outcomes in clinical settings. - Innovative Drug Delivery Systems:
Research on novel drug delivery technologies, including nanoparticles and other advanced formulations, is also featured, aiming to enhance drug efficacy and reduce side effects.
Trending and Emerging
- Integrated Omics Approaches:
There is a significant rise in studies employing integrated omics methodologies (genomics, proteomics, metabolomics) to understand drug mechanisms and disease pathology, reflecting a trend towards holistic research perspectives. - Targeting the Gut Microbiome:
Research focusing on the gut microbiome's role in drug metabolism, efficacy, and disease treatment is gaining traction, highlighting its importance in personalized medicine and therapeutic outcomes. - Emerging Therapeutics and Drug Repurposing:
The journal is increasingly publishing articles on the repurposing of existing drugs for new therapeutic uses, emphasizing the potential of known compounds in treating various diseases. - Nanotechnology in Drug Delivery:
The application of nanotechnology for drug delivery systems is a rapidly growing area, with numerous studies investigating how nanoparticles can enhance the efficacy and safety of therapeutic agents. - Pharmacogenomics and Precision Medicine:
The focus on pharmacogenomics is expanding, with more research dedicated to understanding genetic influences on drug response, which is crucial for developing precision medicine strategies. - Natural Products as Therapeutic Agents:
A resurgence in interest for natural products, including herbal medicines and their bioactive components, is evident, particularly in their roles as potential candidates for innovative therapies.
Declining or Waning
- Conventional Pharmacological Approaches:
There has been a noticeable shift from traditional pharmacological studies towards more integrative and innovative methodologies, including systems biology and multi-omics approaches, reflecting a decline in purely conventional pharmacology research. - Single-Agent Drug Studies:
Research focusing solely on the effects of single-agent drugs is becoming less common, as there is a growing preference for studies that explore combination therapies and polypharmacology to address complex diseases. - Basic Pharmacology without Clinical Relevance:
Papers that do not bridge basic pharmacology with clinical applications are less frequently accepted, indicating a trend towards research that has direct implications for therapeutic practices. - Static Drug Interaction Studies:
The field is moving away from static studies of drug interactions to more dynamic models that incorporate patient-specific factors, highlighting a decline in traditional drug interaction research.
Similar Journals
INDIAN JOURNAL OF PHARMACOLOGY
Connecting academia and industry to shape the future of pharmacology.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
Chinese Journal of Natural Medicines
Bridging Tradition and Modern ScienceThe Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.
European Journal of Pharmacology
Unveiling groundbreaking research in pharmacokinetics and toxicology.The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Fostering Insights in Pharmacology and Toxicology for Better HealthBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.
JOURNAL OF PHARMACY AND PHARMACOLOGY
Pioneering research for transformative healthcare solutions.Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Transforming Ideas into Effective TherapiesDrug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.
Advances in Pharmacological and Pharmaceutical Sciences
Pioneering Insights in Toxicology and Drug Development.Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.
PLANTA MEDICA
Charting New Territories in Herbal ResearchPLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.
DRUG DEVELOPMENT RESEARCH
Illuminating the path to novel therapeutics and safety assessments.DRUG DEVELOPMENT RESEARCH is a premier interdisciplinary journal published by Wiley, focusing on the latest advancements in drug discovery, pharmacology, and toxicology. With an ISSN of 0272-4391 and an E-ISSN of 1098-2299, this esteemed publication has been a cornerstone in the field since its inception in 1981 and continues to provide cutting-edge research until 2024. Its rigorous peer-review process and strategic placement in Q2 of the Drug Discovery category, as well as ranking #60 out of 157 in Scopus, underscore the journal's relevance and influence, boasting a respectable 62nd percentile ranking. While the journal does not currently offer open access, it remains a vital resource for researchers, professionals, and students seeking to expand their knowledge on the processes of drug development, identifying new therapeutic targets, and assessing the efficacy and safety of novel compounds. Situated in Hoboken, NJ, this journal stands at the forefront of pharmaceutical innovation, making significant contributions to the advancement of medical science.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Connecting Researchers with Cutting-Edge Pharmacological InsightsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.